2xo2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Human Annexin V with incorporated Methionine analogue Azidohomoalanine== | ==Human Annexin V with incorporated Methionine analogue Azidohomoalanine== | ||
<StructureSection load='2xo2' size='340' side='right' caption='[[2xo2]], [[Resolution|resolution]] 2.80Å' scene=''> | <StructureSection load='2xo2' size='340' side='right'caption='[[2xo2]], [[Resolution|resolution]] 2.80Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2xo2]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XO2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2XO2 FirstGlance]. <br> | <table><tr><td colspan='2'>[[2xo2]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XO2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2XO2 FirstGlance]. <br> | ||
| Line 15: | Line 15: | ||
==See Also== | ==See Also== | ||
*[[Annexin|Annexin]] | *[[Annexin 3D structures|Annexin 3D structures]] | ||
*[[Cyclin|Cyclin]] | *[[Cyclin|Cyclin]] | ||
== References == | == References == | ||
| Line 22: | Line 22: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Large Structures]] | |||
[[Category: Budisa, N]] | [[Category: Budisa, N]] | ||
[[Category: Debela, M]] | [[Category: Debela, M]] | ||
Revision as of 10:23, 24 April 2019
Human Annexin V with incorporated Methionine analogue AzidohomoalanineHuman Annexin V with incorporated Methionine analogue Azidohomoalanine
Structural highlights
Disease[ANXA5_HUMAN] Defects in ANXA5 are associated with susceptibility to pregnancy loss, recurrent, type 3 (RPRGL3) [MIM:614391]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.[1] Function[ANXA5_HUMAN] This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade. See AlsoReferences
|
| ||||||||||||||||||||